10.28.2009
Special Advances in IBD Program Comes to Denver November 12, 2009
Read more.

9.3.2009
Advances in IBD patient education program coming to Hartford, Albany, Wichita and Kansas City
Read more.

5.12.2009
Special Advances in IBD Patient Education Program to be Presented in Milwaukee on May 28, 2009
Read more.

3.23.2009
Advances in IBD patient education program coming to Scranton, Baltimore, Salt Lake City and Spokane.
Read more.

8.21.2008
Foundation for Clinical Research in Inflammatory Bowel Disease Announces Fall Advances in IBD Series
Read more.

4.22.2008
Cimzia^® Approved in the US for the Treatment of Moderate to Severe Crohn's Disease
Read more.

4.17.2008
Shire USA Announces Education Program for UC Patients
Read more.

1.14.2008
FDA Approves TYSABRI^® for the Treatment of Moderate-to-Severe Crohn's Disease
Read more.

2.27.2007
HUMIRA^® (adalimumab) Receives FDA Approval for Treatment of Crohn’s Disease HUMIRA is the First and Only Self-Administered Biologic Treatment for Moderate to Severe Crohn’s Disease
Read more.

1.17.2007
New Once A Day Oral Treatment for Ulcerative Colitis Approved by the FDA – LIALDA™ with MMX^® Technology to be Available
Read more.

9.01.2006
Fabrizio Michelassi, MD, FACS, Joins Foundation for Clinical Research in Inflammatory Bowel Disease Scientific Advisory Committee
Read more.

8.23.2006
The Foundation Awards New Clinical Grant
Read more.

5.19.2006
Anti-TNF Therapy and the Increased
Risk of Infection and Cancer:
A Statement from the Foundation
for Clinical Research in Inflammatory
Bowel Disease
Read more.

2.01.2006
Foundation for Clinical Research in Inflammatory Bowel Disease Announces New Clinical Research Grant Recipient
Read more.

2.01.2006
Foundation for Clinical Research in Inflammatory Bowel DiseaseAnnounces Spring Advances in IBD Series
Read more.

1.02.2006
Foundation for Clinical Research in Inflammatory Bowel Disease Launches MyIBD.org
Read more.

10.01.2005
Remicade Approved for Ulcerative Colitis
Read more.